1). Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967; 16:178–222.
2). Matucci-Cerinic M, Furst D, Fiorentino D. Skin Manifestations in Rheumatic Disease. New York: Springer;2013. p. 283–8.
Article
3). Mary BFS, Jane W. Kawasaki disease. Kliegman RM, Stanton B, Geme JS, editors. Nelson Textbook of Pediatrics. 20th ed.Philadelphia: Health Sciences;2015. chap. 166.
4). Naoe S, Shibuya K, Takahashi K, et al. Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young. 1991; 1:212–20.
Article
5). Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993; 87:1776–80.
Article
6). Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am. 1999; 46:313–29.
Article
7). Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics. 1999; 104:e10.
Article
8). Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr. 1994; 83:1057–60.
Article
9). Rowley AH, Gonzalez-Crussi F, Gidding SS, et al. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr. 1987; 110:409–13.
Article
10). Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med. 1995; 162:322–7.
11). Levy M, Koren G. Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J. 1990; 9:122–6.
12). Nakamura Y, Yanagawa H, Kato H, Kawasaki T. Mortality rates for patients with a history of Kawasaki disease in Japan. Kawasaki Disease Follow-up Group. J Pediatr. 1996; 128:75–81.
13). Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1994; 89:916–22.
Article
14). Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986; 315:341–7.
Article
15). Burns JC, Joffe L, Sargent RA, Glode MP. Anterior uveitis associated with Kawasaki syndrome. Pediatr Infect Dis. 1985; 4:258–61.
Article
16). Reller M, DeCristofaro J, Schwartz DC. Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol. 1984; 5:205–7.
Article
17). Googe JM Jr, Brady SE, Argyle JC, et al. Choroiditis in infantile periarteritis nodosa. Arch Ophthalmol. 1985; 103:81–3.
Article
18). Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140:509–16.
19). Park YW, Han JW, Park IS. . Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J. 2007; 26:821–3.
Article
20). Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001; 107:E33.
Article
21). Kim DS. Kawasaki disease. Yonsei Med J. 2006; 47:759–72.
Article
22). Heo MY, Choi SJ, Kim HS, Sohn SJ. Clinical features of atypical Kawasaki disease. Korean J Pediatr. 2002; 45:376–82.
23). Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009; 54:1911–20.
24). Bal AK, Prasad D, Pamintuan MA, et al. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease. Pediatr Neonatol. 2014; 55:387–92.
Article
25). Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114:1708–33.
Article
26). Ohno S, Miyajima T, Higuchi M, et al. Ocular manifestations of Kawasaki's disease (mucocutaneous lymph node syndrome). Am J Ophthalmol. 1982; 93:713–7.
Article
27). Anand S, Yang YC. Optic disc changes in Kawasaki disease. J Pediatr Ophthalmol Strabismus. 2004; 41:177–9.
Article
28). Offret H. Disciform keratitis and Kawasaki's disease. J Fr Ophtalmol. 1993; 16:114–6.
29). Kaiura TL, Stoller GL, Florakis GJ. Inflammatory bowel disease and other systemic inflammatory diseases. Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. 3rd ed.St Louis: Mosby;2011. chap. 61.
Article
30). Lindquist TD. Conjunctivitis: an overview and classification. Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. 3rd ed.St Louis: Mosby;2011. chap. 42.
31). Ha SJ, Lee KY, Cha SW, et al. A case of Kawasaki disease diagnosed with the assistance of ophthalmologic examination. Korean J Pediatr. 1999; 42:1014–8.